Constitution Capital
VRTX icon

Constitution Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Constitution Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$209K Buy
+400
New +$205K 0.1% 62
2024
Q4 		– Sell
-1,200
Closed -$558K – 62
2024
Q3 		$558K Buy
1,200
+150
+14% +$72.1K 0.3% 35
2024
Q2 		$492K Hold
1,050
– – 0.26% 43
2024
Q1 		$439K Buy
+1,050
New +$444K 0.25% 41

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Constitution Capital's VRTX Position: Q3 2026 in Review

Constitution Capital opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 400 shares worth $209K. The stake represents 0.1% of the portfolio and ranks #62 among its holdings. This is a return to the name: Constitution Capital previously reported a position in VRTX as recently as Q3 2024.

Constitution Capital first reported a position in VRTX in Q1 2024 and has held it in 4 quarters since. The position peaked at $558K in Q3 2024. 850 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Constitution Capital held 400 shares of Vertex Pharmaceuticals worth $209K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Constitution Capital position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.1% of Constitution Capital's portfolio in Q3 2026, its #62 holding.
  • Constitution Capital first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Constitution Capital's Vertex Pharmaceuticals position peaked at $558K in Q3 2024.
  • 850 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Constitution Capital's 13F filing for Q3 2026, filed 23 Oct 2026.